The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study

<h4>Background</h4> Tuberculosis (TB) is preventable and curable but eliminating it has proven challenging. Safe and effective TB vaccines that can rapidly reduce disease burden are essential for achieving TB elimination. We assessed future costs, cost-savings, and cost-effectiveness of introducing...

Descripció completa

Dades bibliogràfiques

Autors principals:	Allison Portnoy, Rebecca A. Clark, Matthew Quaife, Chathika K. Weerasuriya, Christinah Mukandavire, Roel Bakker, Arminder K. Deol, Shelly Malhotra, Nebiat Gebreselassie, Matteo Zignol, So Yoon Sim, Raymond C. W. Hutubessy, Inés Garcia Baena, Nobuyuki Nishikiori, Mark Jit, Richard G. White, Nicolas A. Menzies
Format:	Artigo
Idioma:	Inglês
Publicat:	Public Library of Science (PLoS) 2023-01-01
Col·lecció:	PLoS Medicine
Accés en línia:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873163/?tool=EBI
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!